A Phase II Trial Of Induction Therapy With Zidovudine, Interleukin-2, And Ganciclovir In The Treatment Of HIV Positive Primary Central Nervous System Lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ganciclovir (Primary) ; Interleukin-2 (Primary) ; Zidovudine (Primary)
- Indications CNS cancer; Lymphoma
- Focus Adverse reactions; Therapeutic Use
- 03 Feb 2016 Biomarkers information updated
- 03 Jul 2007 Status changed from in progress to completed.
- 11 Oct 2005 New trial record.